SHARE
COPY LINK
PRESENTED BY AXA

What’s the reality of expat life in Europe today?

Many of Europe’s 33 million international residents have hit something of a jackpot - at least if recent research is anything to go by.

What’s the reality of expat life in Europe today?
Photo by Danielle MacInnes on Unsplash

From longer parental leave and better educational opportunities to bigger paychecks and career boosters, expats in Europe seem to be enjoying the many perks of living abroad.

One of the greatest appeals of relocating to Europe in particular seems to be the promise of a higher quality of life. A recent survey conducted by Vitreous World on behalf of AXA – Global Healthcare* suggests that expats in Europe are more likely to have packed their bags for better pay and more benefits than for the chance to embark on a new adventure. In France, for example, 31 percent of foreigners say that the French lifestyle is by far the best thing about living there – and about 44 percent benefit from things such as improved pay and learning a new language.

Find out more about AXA’s health insurance packages for expats

Fresh statistics from the world’s longest-running survey of expats* found that, among other things, many European expat hotspots seem to be hitting the high notes on a wide variety of criteria. In Spain, for example, more expats than in any other expat community report that more sun and a slower pace of life has led to significant improvements in both their physical and mental health.** In Switzerland, too, international residents are enthusiastic about their lifestyle upgrade, which includes reaping the benefits of the strong economy (by way of higher-than-global-average salaries) and taking care of their families without having to worry about political instability.*

Photo by Sai De Silva on Unsplash

Despite digital technologies alleviating some of the problems once experienced by expats, living and working abroad does, like most things, have a flipside – or, at any rate, its own set of hurdles. As AXA – Global Healthcare’s survey indicates, these can include language barriers, making new friends, seasonal depression, and adapting to a change in climate. But if you’re aware of these challenges before you move, downloading a language app or joining an online expat community can help you to prepare yourself.

Learn more about how you can benefit from AXA’s global healthcare plans

Moreover, expats often face bureaucratic obstacles as they navigate everything from banking services to local healthcare systems. According to AXA – Global Healthcare’s survey, almost four out of five expats had concerns when seeking healthcare in their current country, with 63 percent saying they would travel back to their home country if they needed medical treatment. Fortunately, you can make use of services such as the Virtual Doctor Service – which is offered with some of AXA’s global health plans with out-patient cover. This provides a handy solution for healthcare challenges if they do arise, allowing you to speak to a doctor at short notice, in a range of languages, at any time and from anywhere in the world.

Photo by Samuel Zeller on Unsplash

On the whole, it does appear that for international dwellers in Europe, expat life comes with many benefits. Although over half of the expats surveyed did report that being away from friends and family made it harder to integrate, and 43 percent said that making new friends was tough, AXA – Global Healthcare’s research indicates that, overall, the majority of both European and global expats believe that their experience of living abroad has been a positive one. For example, close to a majority of expats globally attest to having a better work-life balance than in their home country, citing better leisure opportunities, an easier commute, more disposable income, and more time to spend with family as main reasons.

With AXA’s global health cover, you and your family are covered at every stage of expat life. Find out more about how AXA’s international health insurance can help you to get the most out of life abroad.

*Research conducted in February 2019 by Vitreous World on behalf of AXA. A total of 1,352 expats were surveyed (250 in the UK, France, UAE, Canada and China, and 100 in Hong Kong).

**HSBC Expat Explorer Survey 2019

This article was produced by The Local Creative Studio and presented by AXA.

AXA Global Healthcare (EU) Limited. Registered in Ireland number 630468. Registered Office: Wolfe Tone House, Wolfe Tone Street, Dublin 1. AXA Global Healthcare (EU) Limited is regulated by the Central Bank of Ireland.

AXA Global Healthcare (UK) Limited. Registered in England (No. 03039521). Registered Office: 20 Gracechurch Street, London, EC3V 0BG, United Kingdom. AXA Global Healthcare (UK) Limited is authorised and regulated in the UK by the Financial Conduct Authority.

 

HEALTH

‘Possible link’ between AstraZeneca vaccine and rare blood clots, EMA concludes

The European Medicines Agency has come to the conclusion that the unusual blood clots suffered by numerous people around Europe should be considered as rare side effects of AstraZeneca's Covid-19 vaccine, but that overall the benefits of the jab outweigh the risk.

'Possible link' between AstraZeneca vaccine and rare blood clots, EMA concludes
Photo by Tiziana FABI / AFP

A statement published online read: “The EMA’s safety committee has concluded today that unusual blood clots with low blood platelets should be listed as very rare side effects of the COVID-19 AstraZeneca vaccine.”

The EMA added however that the benefits of the vaccine outweigh the risks.

While millions of doses of the vaccine developed with Oxford University have been administered, small numbers of people have developed deadly blood clots, which prompted countries including the European Union’s three largest nations – Germany, France and Italy – to temporarily suspend injections pending the EMA investigation.

In March the EMA said the vaccine was “safe and effective” in protecting people against Covid-19 but that it couldn’t rule out a link to blood clots, and that more investigations were needed.

On Wednesday the EMA said the AstraZeneca vaccine should continue to be used for all age groups but that people should be told of the possible rare side effects. The announcement came as the UK’s own drugs regulator said the AZ vaccine should now only be given to over 30s.

The EMA said it was “reminding healthcare professionals and people receiving the vaccine to remain aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within two weeks of vaccination.”

One plausible explanation for the combination of blood clots and low blood platelets is an immune response, the EMA said but that it had not identified any clear risk factors for causing the clots including age or gender.

So far, most of the cases reported have occurred in women under 60 years of age within two weeks of vaccination. 

The EMA advised that people who have received the vaccine should seek medical assistance immediately if they develop symptoms of this combination of blood clots and low blood platelets.

Symptoms include shortness of breath, chest pain, swelling in legs, abdominal pain, severe headaches, blurred vision and tiny blood spots under the skin at the sight of the injection.

The EMA committee carried out an in-depth review of 62 cases of cerebral venous sinus thrombosis and 24 cases of splanchnic vein thrombosis reported in the EU drug safety database (EudraVigilance) as of 22 March 2021, 18 of which were fatal

The agency concluded: “COVID-19 is associated with a risk of hospitalisation and death. The reported combination of blood clots and low blood platelets is very rare, and the overall benefits of the vaccine in preventing COVID-19 outweigh the risks of side effects.”

Germany, France and Italy have all restarted AstraZeneca vaccines, but in the case of France and Germany with extra guidelines on the age of patients it should be used for. France is currently not administering the AstraZeneca vaccine to under 55s or over 75s.

SHOW COMMENTS